greeksoup/ stock research

Johnson & Johnson (JNJ) FY2009 results: revenue $61.9 billion, down 2.9% on the year

Johnson & Johnson (JNJ) reported revenue of $61.9 billion for fiscal 2009, the year ended 3 January 2010, down 2.9% on the year before. Net income was $12.3 billion, down 5.3%, and diluted earnings per share $4.40. The figures are the company's own, from the 10-K it filed with the SEC on 1 March 2010.

Revenue
$61.9 billion
-2.9% on the year
FY2007FY2009
Operating margin
26.8%
FY2007FY2009
Net income
$12.3 billion
-5.3% on the year
FY2007FY2009
Diluted EPS
$4.40
-3.7% on the year
FY2007FY2009

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2009FY2008FY2007On the yearLast 8 years
Revenue61,89763,74761,095-2.9%
Cost of revenue18,44718,51117,751-0.3%
Gross profit43,45045,23643,344-3.9%
Gross margin70.2%71.0%70.9%
Research and development6,9867,5777,680-7.8%
Selling, general and administrative19,80121,49020,451-7.9%
Operating income16,582n/an/a
Operating margin26.8%n/an/a
Interest expense451435296+3.7%
Pre-tax income15,75516,92913,283-6.9%
Income tax3,4893,9802,707-12.3%
Effective tax rate22.1%23.5%20.4%
Net income12,26612,94910,576-5.3%
Net margin19.8%20.3%17.3%
Diluted EPS$4.40$4.57$3.63-3.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2009FY2008FY2007On the yearLast 8 years
Operating cash flow16,57114,97215,022+10.7%
Capital expenditure2,3653,0662,942-22.9%
Free cash flow14,20611,90612,080+19.3%
Free cash flow margin23.0%18.7%19.8%
Cash from investing-7,598-4,187-5,912
Cash from financing-4,092-7,464-5,698
Depreciation and amortisation2,7742,8322,777-2.0%
Share-based compensation628627698+0.2%
Buybacks2,1306,6515,607-68.0%
Dividends paid5,3275,0244,670+6.0%
Dividend per share$1.93$1.79$1.62+7.5%
Diluted shares, weighted2,789m2,836m2,911m-1.6%

Balance sheet

$ millionFY2009FY2008FY2007On the yearLast 8 years
Shareholders' equity50,58842,51143,319+19.0%
Short-term borrowings6,3183,732n/a+69.3%
Debt8,2578,120n/a+1.7%
Other liabilities29,51930,549n/a-3.4%
Total liabilities and equity94,68284,912n/a+11.5%
Fixed assets14,75914,365n/a+2.7%
Goodwill14,86213,719n/a+8.3%
Intangible assets16,32313,976n/a+16.8%
Investments3,6152,045n/a+76.8%
Cash and equivalents15,81010,7687,770+46.8%
Receivables9,6469,719n/a-0.8%
Inventory5,1805,052n/a+2.5%
Other assets14,48715,268n/a-5.1%
Total assets94,68284,912n/a+11.5%

10-K for the year ended 3 January 2010, filed 1 March 2010: the filing.